Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019–21)

BACKGROUND: Aztreonam/avibactam is under development to treat infections caused by Gram-negative bacteria. We evaluated the in vitro activities of aztreonam/avibactam and comparators against a global collection of carbapenem-resistant Enterobacterales (CRE), including ceftazidime/avibactam-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Castanheira, Mariana, Kimbrough, John H, Kantro, Valerie, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032302/
https://www.ncbi.nlm.nih.gov/pubmed/36968952
http://dx.doi.org/10.1093/jacamr/dlad032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032302/
https://www.ncbi.nlm.nih.gov/pubmed/36968952
http://dx.doi.org/10.1093/jacamr/dlad032

Ejemplares similares